Here, we examined in vitro whether (i) E. coli infection and leucine supplementation alter the energy metabolism in CBMo and PBMo exceedingly and (ii) whether the signaling induced by leucine and infection affects the AKT/mTOR checkpoint with comparable reactions in CBMo and PBMo. The gene discussed is MTOR; the disease is escherichia coli infection.